These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12488404)

  • 1. "The guard dies, it does not surrender!" progress in the management of small-cell lung cancer?
    Johnson DH
    J Clin Oncol; 2002 Dec; 20(24):4618-20. PubMed ID: 12488404
    [No Abstract]   [Full Text] [Related]  

  • 2. Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: results from a randomized phase III trial with 5 years' follow-up.
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Hatlevoll R; Dahle R; Boye N; Wang M; Vigander T; Vilsvik J; Skovlund E; Hannisdal E; Aamdal S;
    J Clin Oncol; 2002 Dec; 20(24):4665-72. PubMed ID: 12488411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide, etoposide, and infusion cisplatin in refractory small cell lung cancer. A preliminary report.
    Frytak S; Eagan RT; Richardson RL; Creagan ET; Jett JL; Coles DT; Lee RE
    Am J Clin Oncol; 1987 Feb; 10(1):33-5. PubMed ID: 3030092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer.
    Einhorn LH; Crawford J; Birch R; Omura G; Johnson DH; Greco FA
    J Clin Oncol; 1988 Mar; 6(3):451-6. PubMed ID: 2832549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small cell lung cancer trials in the EORTC.
    van Zandwijk N; McVie JG; Dalesio O; Kirkpatrick A
    Eur J Respir Dis Suppl; 1987; 149():57-62. PubMed ID: 3034650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in the treatment of ED small cell lung cancer].
    Nokihara H; Ohe Y
    Nihon Rinsho; 2002 May; 60 Suppl 5():480-4. PubMed ID: 12101718
    [No Abstract]   [Full Text] [Related]  

  • 7. Early crossover of induction chemotherapy in small cell lung carcinoma.
    Robinson PC; Gill PG; Antic R; Drew MJ; McLennan G
    Aust N Z J Med; 1983 Feb; 13(1):21-5. PubMed ID: 6309130
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase II study of cyclophosphamide, doxorubicin, and vincristine (CAV) and etoposide plus cisplatin (EP) alternating chemotherapy combined with radiotherapy in small cell lung cancer.
    Park YJ; Koh EH; Kim J; Roh JK; Chang J; Ahn CM; Sohn HY; Kim SK; Lee WY; Kim K
    Yonsei Med J; 1989; 30(1):30-7. PubMed ID: 2545051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer].
    Abad-Esteve A; Rosell R; Moreno I; Fernández-Marcial C; Roselló M; Ribas Mundó M
    Med Clin (Barc); 1988 Apr; 90(14):569-72. PubMed ID: 2840536
    [No Abstract]   [Full Text] [Related]  

  • 10. An evaluation of low-dose cisplatin as part of combined modality therapy of limited small cell lung cancer.
    Eagan RT; Lee RE; Frytak S; Fleming TR; Ingle JN; Creagan ET; Nichols WC; Kvols LK; Coles DT
    Cancer Clin Trials; 1981; 4(3):267-71. PubMed ID: 6269770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is small cell lung cancer an orphan disease?].
    Pujol JL
    Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S22-4. PubMed ID: 16719152
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy of small cell lung cancer].
    Komiya T; Takada M
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1116-23. PubMed ID: 8751797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cell lung cancer and chemotherapy.
    Nardini S
    Monaldi Arch Chest Dis; 1994 Apr; 49(2):178-9. PubMed ID: 8049707
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognostic factors in limited-stage small cell lung cancer of patients treated with combined modality approach.
    Cetingöz R; Cetinayak HO; Sen RC; Demiral AN; Akkoçlu A; Osma E; Kargi A; Oztop I; Onen A; Kinay M;
    J BUON; 2006; 11(1):31-7. PubMed ID: 17318949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant chemotherapy of lung cancer].
    Yamaguchi Y; Urabe N; Momiki S; Obata S; Ogawa T; Kimura H
    Rinsho Kyobu Geka; 1987; 7(5):448-52. PubMed ID: 9301798
    [No Abstract]   [Full Text] [Related]  

  • 17. Etoposide combined with cyclophosphamide plus vincristine compared with doxorubicin plus cyclophosphamide plus vincristine and with high-dose cyclophosphamide plus vincristine in the treatment of small-cell carcinoma of the lung: a randomized trial of the Bristol Lung Cancer Study Group.
    Hong WK; Nicaise C; Lawson R; Maroun JA; Comis R; Speer J; Luedke D; Hurtubise M; Lanzotti V; Goodlow J
    J Clin Oncol; 1989 Apr; 7(4):450-6. PubMed ID: 2538577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polychemotherapeutic treatment in undifferentiated small cell carcinoma of the lung].
    Illiano A; Giacomelli P; Tremiterra E; Scivicco S; Bariffi F; Olivieri D
    Arch Monaldi; 1983; 38(1-2):53-7. PubMed ID: 6326702
    [No Abstract]   [Full Text] [Related]  

  • 19. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy in extended small-cell lung cancer. Retrospective analysis of two different series of patients treated with carboplatin and etoposide or ciclophosphamide-epidoxorubicin and etoposide].
    Tassinari D; Genestreti G; Pasquini E; Fantini M; Poggi B; Tamburini E; Papi M; Ioli G; Oliverio G; Fochessati F; Arcangeli V; Agostini V; Mianulli AM; Imola M; Fattori PP; Ravaioli A
    Recenti Prog Med; 2005 May; 96(5):234-9. PubMed ID: 15977652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.